Megestrol Acetate Patent Expiration
Megestrol Acetate is Used for treating anorexia, cachexia, or unexplained significant weight loss in AIDS patients. It was first introduced by Bristol Myers Squibb
Megestrol Acetate Patents
Given below is the list of patents protecting Megestrol Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Megace Es | US7101576 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
| Megace Es | US9040088 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
| Megace Es | US9101540 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
| Megace Es | US9101549 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
| Megace Es | US9107827 | Nanoparticulate megestrol formulations |
Apr 22, 2024
(Expired) | Endo Operations |
| Megace Es | US6592903 | Nanoparticulate dispersions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
Sep 21, 2020
(Expired) | Endo Operations |
About Veterinary Megestrol Acetate
Megestrol Acetate is used in a drug marketed by 1 company: Intervet Inc
Other drugs containing Megestrol Acetate are: Ovaban tablets 20 mg, ovaban tablets 5 mg ,
Megestrol Acetate's Family Patents
